ORBIMED CAPITAL LLC
Director, 10% Owner · 1 filing · Latest: Apr 21, 2026
Prelude Therapeutics Inc
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
ELVN | The Biotech Growth Trust PLC | — | Jun 22, 2026 | Proposed Sale | $45.96 | 31,132 | $1.4M | — | |
ELVN | The Biotech Growth Trust PLC | — | Jun 15, 2026 | Proposed Sale | $42.36 | 10,243 | $433.9K | — | |
PRLD | ORBIMED CAPITAL LLC | Director, 10% Owner | Apr 21, 2026 | Purchase | $4.44 | 2,815,315 | $12.5M | 1,126,126 | |
CMPX | The Biotech Growth Trust PLC | — | Apr 9, 2025 | Proposed Sale | $1.59 | 3,571,428 | $5.7M | — | |
PASG | Worldwide Healthcare Trust PLC | — | Dec 4, 2024 | Proposed Sale | $0.89 | 2,028,307 | $1.8M | — | |
PASG | Worldwide Healthcare Trust PLC | — | Sep 16, 2024 | Proposed Sale | $0.807 | 241,328 | $194.8K | — | |
SPRY | OrbiMed Partners Master Fund Limited | — | Aug 21, 2024 | Proposed Sale | $14.89 | 952,377 | $14.2M | — |